5.65
5.65 (-1.99%)
As of Feb 09, 2023
Macrogenics Inc [MGNX]
Source:
Company Overview
Macrogenics Inc is a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for the treatment of cancer. We have a pipeline of product candidates being evaluated in clinical trials sponsored by us or our collaborators. These product candidates include six immuno-oncology programs, many of which were created using our proprietary, antibody-based technology platforms.
Country | United States |
Headquarters | rockville, maryland |
Phone Number | 301-251-5172 |
Industry | manufacturing |
CEO | Scott Koenig, M.D., Ph.D. |
Website | www.macrogenics.com |